FindTrial
Sign In

The research of the ticagrelor and the clopidogrel in improving the slow flow / no- reflow in the interventional surgery of acute coronary syndrome (ACS) patients and the impact of cardiovascular and cerebrovascular events in post-operative

The research of the ticagrelor and the clopidogrel in improving the slow flow / no- reflow in the interventional surgery of acute coronary syndrome (ACS) patients and the impact of cardiovascular and cerebrovascular events in post-operative

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003923
Enrollment
Unknown
Registered
2013-06-25
Start date
2013-03-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

Ticagrelor:Ticagrelor
clopidogrel:clopidogrel

Sponsors

Cardiology of Zhujiang hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: acute coronary syndrome patients following percutaneous coronary intervention;Irrespective of the patient's age.

Exclusion criteria

Exclusion criteria: stable angina

Design outcomes

Primary

MeasureTime frame
Slow flow / no-reflow Incidenc;—

Secondary

MeasureTime frame
Cardiac death;myocardial infarction;stroke;all reason death;—

Countries

China

Contacts

Public ContactZhang Peidong

Zhujiang Hospital of Southern Medical University

18665000976@163.com+86 18665000976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026